Has the worst been and gone for A2 Milk shares?

Are things sweet or sour for this fallen dairy business?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • COVID-19 was a tough time for A2 Milk, with a number of earnings downgrades
  • But, it's now expecting growth in FY23 and it has been approved to import infant formula into the US
  • Experts think that the business is turning around

The A2 Milk Company Ltd (ASX: A2M) share price has seen plenty of volatility over the last couple of years.

Since the start of July 2020, A2 Milk shares have fallen by around 70%.

But, interestingly, the company has gone on a strong run over the past six months, rising by 44%.

So, with the recent rise from the low, can investors say that the worst is over?

A woman sits with a glass of milk in front of her as she puts a finger to the side of her face as though in thought while her eyes look to the side as though she is contemplating something.

Image source: Getty Images

A2 Milk is expecting growth

After a couple of years of revenue declines, with regular earnings downgrades, A2 Milk is finally expecting to deliver growth again.

When the dairy company announced its FY22 result, it also gave some comments about expectations for FY23. It said that it's expecting continued revenue and earnings growth.

The company said that it's expecting high single-digit growth in FY23. FY23 first-half growth is expected to be "significantly higher" than the FY23 second half.

The FY23 gross profit margin is expected to be "broadly in line" with FY22, with cost of goods sold headwinds related to increasing milk, ingredient and packaging costs offset by price increases, product mix benefits and cost mitigation initiatives.

Overall, the business is expecting earnings before interest, tax, depreciation and amortisation (EBITDA) growth in FY23 and a modest improvement in the EBITDA margin. It's expecting the FY23 second-half EBITDA margin to be better than the first half.

Is the worst over?

The latest win for the business came as the United States Food and Drug Administration approved A2 Milk to supply infant milk formula to the US to help with the shortage there.

The FDA had deferred further consideration of A2 Milk's US application. But, after ongoing engagement with the FDA, the agency has given A2 Milk approval to supply infant formula. The business is expecting to sell up to 1 million cans, all within the second half of FY23.

According to reporting by the Australian Financial Review, Spheria Asset Management portfolio manager Matt Booker said:

It's done reasonably well despite the challenges and headwinds, particularly in China. They are growing again, and rolling out into more stores there.

My feeling is they won that a2 category years ago. They sold the brand hard into China, and it's hard to displace – consumers tend not to like copycats and rather have the original brand. I think the brand still resonates with Chinese consumers.

They are coming off that low base in terms of margins. I think they can get back to the 20 per cent EBITDA margins from where they are now. This is a far more sustainable business today.

The AFR also referred to Barrenjoey head of consumer research Tom Kierath liking the ASX share, saying the US news is incrementally positive, but not a "game changer", and China remains its opportunity.

Snapshot

Over the last month, the A2 Milk share price is up around 4%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

One hundred dollar notes planted in the ground, representing ASX growth shares.
Best Shares

This 4% ASX stock is my top pick for growth and income in 2026

Stocks of this calibre are exceptionally rare...

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

A shadow bear faces a man against the backdrop of a falling share price.
Opinions

How to invest during an ASX share bear market when you're worried about prices falling more

Is this the time to be brave or cautious about investing?

Read more »

Ecstatic woman on her phone giving a fist pump after reading some good news.
Opinions

5 ASX shares I'd buy with $10,000 this week

I expect these shares to rebound over the next 12 months.

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Opinions

2 incredible ASX shares to buy in April

I rate these potential investments as exciting buys…

Read more »

Two people lazing in deck chairs on a beautiful sandy beach throw their hands up in the air.
Retirement

Why Soul Patts shares are a retiree's dream

This could be one of the best picks for retirees. Here’s why.

Read more »

Different Australian dollar notes in the palm of two hands, symbolising dividends.
Dividend Investing

An ASX dividend stalwart every Australian should consider buying

This business has a great track dividend record. I think it’s a strong buy…

Read more »

Three business people stand on platforms in the desert and look out through telescopes.
Opinions

2 top ASX shares to buy and hold for the next decade

I think these businesses have a great future…

Read more »